{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:09:06Z","timestamp":1792098546235,"version":"4.4.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008064","name":"Georgetown University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008064","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004853","name":"Chinese University of Hong Kong","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004853","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005407","name":"Food and Health Bureau","doi-asserted-by":"publisher","award":["3132968"],"award-info":[{"award-number":["3132968"]}],"id":[{"id":"10.13039\/501100005407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","award":["08090481"],"award-info":[{"award-number":["08090481"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.apsb.2020.12.021","type":"journal-article","created":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T02:07:42Z","timestamp":1610244462000},"page":"1885-1902","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Polyoxypregnanes as safe, potent, and specific ABCB1-inhibitory pro-drugs to overcome multidrug resistance in cancer chemotherapy in\u00a0vitro and in\u00a0vivo"],"prefix":"10.1016","volume":"11","author":[{"given":"Xu","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9807-8444","authenticated-orcid":false,"given":"Stella","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4467-6155","authenticated-orcid":false,"given":"Chunyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onat","family":"Kadioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Efferth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth Kin-Wah","family":"To","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2020.12.021_bib1","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1126\/science.1168750","article-title":"Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding","volume":"323","author":"Aller","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.apsb.2020.12.021_bib2","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0005-2736(76)90160-7","article-title":"A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants","volume":"455","author":"Juliano","year":"1976","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.apsb.2020.12.021_bib3","first-page":"1671","article-title":"Overexpression and amplification of five genes in a multidrug-resistant Chinese hamster ovary cell line","volume":"6","author":"Van der Bliek","year":"1986","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.apsb.2020.12.021_bib4","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2174\/15680096113139990076","article-title":"P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives","volume":"13","author":"Binkhathlan","year":"2013","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.apsb.2020.12.021_bib5","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/978-1-60761-416-6_15","article-title":"Overcoming multidrug resistance in cancer: clinical studies of P-glycoprotein inhibitors","volume":"596","author":"Coley","year":"2010","journal-title":"Multi-Drug Resist Cancer"},{"key":"10.1016\/j.apsb.2020.12.021_bib6","doi-asserted-by":"crossref","first-page":"722","DOI":"10.2174\/138920011798357006","article-title":"P-glycoprotein inhibition: the past, the present and the future","volume":"12","author":"Darby","year":"2011","journal-title":"Curr Drug Metabol"},{"key":"10.1016\/j.apsb.2020.12.021_bib7","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s00280-015-2845-1","article-title":"Pharmacokinetic and pharmacodynamic study of tariquidar (XR9576), a P-glycoprotein inhibitor, in combination with doxorubicin, vinorelbine, or docetaxel in children and adolescents with refractory solid tumors","volume":"76","author":"Fox","year":"2015","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.apsb.2020.12.021_bib8","first-page":"159","article-title":"Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoprotein","volume":"10","author":"Thomas","year":"2003","journal-title":"Can Contract"},{"key":"10.1016\/j.apsb.2020.12.021_bib9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.canlet.2017.03.011","article-title":"Regorafenib overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter in colorectal cancer: in\u00a0vitro and in\u00a0vivo study","volume":"396","author":"Wang","year":"2017","journal-title":"Cancer Lett"},{"key":"10.1016\/j.apsb.2020.12.021_bib10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.canlet.2018.07.022","article-title":"The positive inotropic agent DPI-201106 selectively reverses ABCB1-mediated multidrug resistance in cancer cell lines","volume":"434","author":"Hsiao","year":"2018","journal-title":"Cancer Lett"},{"key":"10.1016\/j.apsb.2020.12.021_bib11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1517\/17425255.4.2.205","article-title":"Development of inhibitors of ATP-binding cassette drug transporters: present status and challenges","volume":"4","author":"Shukla","year":"2008","journal-title":"Expet Opin Drug Metabol Toxicol"},{"key":"10.1016\/j.apsb.2020.12.021_bib12","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/cmdc.201300233","article-title":"Interactions of the multidrug resistance modulators tariquidar and elacridar and their analogues with P-glycoprotein","volume":"8","author":"Pajeva","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.apsb.2020.12.021_bib13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.lungcan.2011.06.001","article-title":"Marsdenia tenacissima extract restored gefitinib sensitivity in resistant non-small cell lung cancer cells","volume":"75","author":"Han","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.apsb.2020.12.021_bib14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0254-6272(13)60097-7","article-title":"Effect of Xiaoaiping injection on advanced hepatocellular carcinoma in patients","volume":"33","author":"Huang","year":"2013","journal-title":"J Tradit Chin Med"},{"key":"10.1016\/j.apsb.2020.12.021_bib15","first-page":"83","article-title":"Effect of xiaoaiping injection combined with TP regimen in the treatment of advanced non-small cell lung cancer","volume":"22","author":"Xia","year":"2013","journal-title":"Proc Clin Med"},{"key":"10.1016\/j.apsb.2020.12.021_bib16","doi-asserted-by":"crossref","first-page":"13965","DOI":"10.3390\/molecules190913965","article-title":"Total aglycones from Marsdenia tenacissima increases antitumor efficacy of paclitaxel in nude mice","volume":"19","author":"Zhu","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.apsb.2020.12.021_bib17","first-page":"14","article-title":"Clinical study on cancer-eliminating injection by intervention therapy through hepatic artery in metastatic liver cancer Shanghai","volume":"34","author":"Sun","year":"2000","journal-title":"J Tradit Chin Med"},{"key":"10.1016\/j.apsb.2020.12.021_bib18","first-page":"936","article-title":"A random study of xiaoaiping injection combined with chemotherapy on the treatment of advanced non-small cell lung cancer","volume":"14","author":"Wang","year":"2009","journal-title":"Chin Clin Oncol"},{"key":"10.1016\/j.apsb.2020.12.021_bib19","first-page":"97","article-title":"Clinical research of combined xiaoaiping injection with chemotherapy on advanced non-small cell lung cancer","volume":"12","author":"Huang","year":"2007","journal-title":"Chin Clin Oncol"},{"key":"10.1016\/j.apsb.2020.12.021_bib20","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1021\/np070458f","article-title":"Tenacigenin B derivatives reverse P-glycoprotein-mediated multidrug resistance in HepG2\/Dox cells","volume":"71","author":"Hu","year":"2008","journal-title":"J Nat Prod"},{"key":"10.1016\/j.apsb.2020.12.021_bib21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.phytochem.2016.03.006","article-title":"Polyoxypregnane steroids with an open-chain sugar moiety from Marsdenia tenacissima and their chemoresistance reversal activity","volume":"126","author":"Yao","year":"2016","journal-title":"Phytochemistry"},{"key":"10.1016\/j.apsb.2020.12.021_bib22","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1021\/np500385b","article-title":"Polyoxypregnane steroids from the stems of Marsdenia tenacissima","volume":"77","author":"Yao","year":"2014","journal-title":"J Nat Prod"},{"key":"10.1016\/j.apsb.2020.12.021_bib23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jpba.2017.06.038","article-title":"Adduct ion-targeted qualitative and quantitative analysis of polyoxypregnanes by ultra-high pressure liquid chromatography coupled with triple quadrupole mass spectrometry","volume":"145","author":"Wu","year":"2017","journal-title":"J Pharmaceut Biomed Anal"},{"key":"10.1016\/j.apsb.2020.12.021_bib24","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jep.2017.03.051","article-title":"Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes","volume":"203","author":"To","year":"2017","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.apsb.2020.12.021_bib25","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/ijc.2910490512","article-title":"P-glycoprotein expression and schedule dependence of adriamycin cytotoxicity in human colon carcinoma cell lines","volume":"49","author":"Lai","year":"1991","journal-title":"Int J Cancer"},{"key":"10.1016\/j.apsb.2020.12.021_bib26","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.ejmech.2015.06.049","article-title":"Reversal of P-gp and BCRP-mediated MDR by tariquidar derivatives","volume":"101","author":"Li","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2020.12.021_bib27","doi-asserted-by":"crossref","first-page":"5770","DOI":"10.1021\/jf1005885","article-title":"Characterization of metabolism and in\u00a0vitro permeability study of notoginsenoside R1 from Radix notoginseng","volume":"58","author":"Ruan","year":"2010","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.apsb.2020.12.021_bib28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00204-010-0587-8","article-title":"In\u00a0vitro study of P-glycoprotein induction as an antidotal pathway to prevent cytotoxicity in Caco-2 cells","volume":"85","author":"Silva","year":"2011","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.apsb.2020.12.021_bib29","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bcp.2016.01.014","article-title":"Interactions of human P-glycoprotein transport substrates and inhibitors at the drug binding domain: functional and molecular docking analyses","volume":"104","author":"Kadioglu","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.apsb.2020.12.021_bib30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejps.2004.10.006","article-title":"Multiple P450 substrates in a single run: rapid and comprehensive in\u00a0vitro interaction assay","volume":"24","author":"Turpeinen","year":"2005","journal-title":"Eur J Pharmaceut Sci"},{"key":"10.1016\/j.apsb.2020.12.021_bib31","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00204-016-1713-z","article-title":"The long persistence of pyrrolizidine alkaloid-derived DNA adducts in\u00a0vivo: kinetic study following single and multiple exposures in male ICR mice","volume":"91","author":"Zhu","year":"2017","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.apsb.2020.12.021_bib32","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/S0021-9258(20)82245-5","article-title":"The carbon monoxide-binding pigment of liver microsomes. II. Solubilization, purification, and properties","volume":"239","author":"Omura","year":"1964","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2020.12.021_bib33","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nature05630","article-title":"Multiple molecular mechanisms for multidrug resistance transporters","volume":"446","author":"Higgins","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2020.12.021_bib34","doi-asserted-by":"crossref","first-page":"26806","DOI":"10.1074\/jbc.M112.376202","article-title":"The ATPase activity of the P-glycoprotein drug pump is highly activated when the N-terminal and central regions of the nucleotide-binding domains are linked closely together","volume":"287","author":"Loo","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2020.12.021_bib35","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1248\/bpb.28.316","article-title":"In\u00a0vivo effects of cyclosporin A and ketoconazole on the pharmacokinetics of representative substrates for P-glycoprotein and cytochrome P450 (CYP) 3A in rats","volume":"28","author":"Kageyama","year":"2005","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.apsb.2020.12.021_bib36","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/bdd.754","article-title":"Effects of oral curcumin on the pharmacokinetics of intravenous and oral etoposide in rats: possible role of intestinal CYP3A and P-gp inhibition by curcumin","volume":"32","author":"Lee","year":"2011","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.apsb.2020.12.021_bib37","first-page":"109","article-title":"Study on the influence of silymarin pretreatment on metabolism and disposition of metronidazole","volume":"54","author":"Rajnarayana","year":"2004","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.apsb.2020.12.021_bib38","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1124\/dmd.106.011072","article-title":"Impact of curcumin-induced changes in P-glycoprotein and CYP3A expression on the pharmacokinetics of peroral celiprolol and midazolam in rats","volume":"35","author":"Zhang","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.apsb.2020.12.021_bib39","first-page":"802","article-title":"The multidrug resistance modulator valspodar (PSC 833) is metabolized by human cytochrome P450 3A \u2014 implications for drug-drug interactions and pharmacological activity of the main metabolite","volume":"26","author":"Fischer","year":"1998","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.apsb.2020.12.021_bib40","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1586\/14737140.7.4.447","article-title":"Tariquidar (XR9576): a P-glycoprotein drug efflux pump inhibitor","volume":"7","author":"Fox","year":"2007","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.apsb.2020.12.021_bib41","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1021\/cn100078a","article-title":"The \u201cspecific\u201d P-glycoprotein inhibitor tariquidar is also a substrate and an inhibitor for breast cancer resistance protein (BCRP\/ABCG2)","volume":"2","author":"Kannan","year":"2011","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.apsb.2020.12.021_bib42","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/ijc.2910560523","article-title":"Verapamil decreases P-glycoprotein expression in multidrug-resistant human leukemic cell lines","volume":"56","author":"Muller","year":"1994","journal-title":"Int J Cancer"},{"key":"10.1016\/j.apsb.2020.12.021_bib43","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s00280-009-1121-7","article-title":"PSC833, cyclosporine analogue, downregulates MDR1 expression by activating JNK\/c-Jun\/AP-1 and suppressing NF-kappaB","volume":"65","author":"Bark","year":"2010","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.apsb.2020.12.021_bib44","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/bdd.523","article-title":"Effects of naringin on the pharmacokinetics of intravenous paclitaxel in rats","volume":"27","author":"Lim","year":"2006","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.apsb.2020.12.021_bib45","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12906-019-2795-y","article-title":"Xiao-ai-ping injection adjunct with platinum-based chemotherapy for advanced non-small-cell lung cancer: a systematic review and meta-analysis","volume":"20","author":"Feng","year":"2020","journal-title":"BMC Complement Med Ther"},{"key":"10.1016\/j.apsb.2020.12.021_bib46","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1186\/s12906-019-2779-y","article-title":"Oral and injectable Marsdenia tenacissima extract (MTE) as adjuvant therapy to chemotherapy for gastric cancer: a systematic review","volume":"19","author":"Zhou","year":"2019","journal-title":"BMC Compl Alternative Med"},{"key":"10.1016\/j.apsb.2020.12.021_bib47","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3109\/10428194.2015.1043546","article-title":"Marsdenia tenacssima extract and its functional components inhibits proliferation and induces apoptosis of human Burkitt leukemia\/lymphoma cells in\u00a0vitro and in\u00a0vivo","volume":"57","author":"Li","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.apsb.2020.12.021_bib48","first-page":"29","article-title":"In\u00a0vitro and in\u00a0vivo antitumor activities of tenacissoside C from Marsdenia tenacissima","volume":"80","author":"Ye","year":"2014","journal-title":"Planta Med"},{"key":"10.1016\/j.apsb.2020.12.021_bib49","doi-asserted-by":"crossref","DOI":"10.1177\/1534735420906463","article-title":"Xiao-ai-ping injection enhances effect of paclitaxel to suppress breast cancer proliferation and metastasis via activating transcription factor 3","volume":"19","author":"Chen","year":"2020","journal-title":"Integr Cancer Ther"},{"key":"10.1016\/j.apsb.2020.12.021_bib50","doi-asserted-by":"crossref","first-page":"113067","DOI":"10.1016\/j.jep.2020.113067","article-title":"Xiaoaiping injection enhances paclitaxel efficacy in ovarian cancer via pregnane X receptor and its downstream molecules","volume":"261","author":"Zhang","year":"2020","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.apsb.2020.12.021_bib51","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jep.2019.02.028","article-title":"Tenacigenin B ester derivatives from Marsdenia tenacissima actively inhibited CYP3A4 and enhanced in\u00a0vivo antitumor activity of paclitaxel","volume":"235","author":"Xie","year":"2019","journal-title":"J Ethnopharmacol"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383521000034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383521000034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:49:50Z","timestamp":1761929390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383521000034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S2211383521000034"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2020.12.021","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polyoxypregnanes as safe, potent, and specific ABCB1-inhibitory pro-drugs to overcome multidrug resistance in cancer chemotherapy in\u00a0vitro and in\u00a0vivo","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2020.12.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}